J.P. Estève - Concepedia

Author

J.P. Estève

Also Known As

J ESTEVE, J P Esteve, J P Estève, J P Estéve, J. Esteve, J. P. ESTEVE, J. P. ESTÈVE, J. P. Esteve, J. P. Estève, J.-P. Esteve

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Inserm Hôpital Rangueil Tulane University University of Chicago

About

J.P. Estève is an author at Inserm specializing in medicine, endocrinology, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	25	1.6K
2	Biochemistry	12	13	661
3	Natural Sciences	6	6	463
4	Biomolecular Engineering	3	3	73
5	Engineering	2	2	46

J.P. Estève

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes SSTR1 and SSTR2. Louis Buscail, Nathalie Delesque, J.P. Estève, Proceedings of the National Academy of Sciences ImmunologyMolecular PharmacologySignaling PathwayReceptor Tyrosine KinaseTyrosine Phosphatase	1994	330
Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms. Louis Buscail, J.P. Estève, Nathalie Saint‐Laurent, Proceedings of the National Academy of Sciences SclerostinSignal TransductionMolecular PhysiologySignaling PathwayMedicine	1995	295
sst2 Somatostatin Receptor Mediates Cell Cycle Arrest and Induction of p27 Philippe Pagès, Naoual Benali, Nathalie Saint‐Laurent, Journal of Biological Chemistry Signal TransductionDevelopmental BiologyCell RegulationSignaling PathwayReceptor Tyrosine Kinase	1999	131
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells. Nathalie Delesque, Louis Buscail, J.P. Estève, PubMed Pancreatic CancerSst2 DefectCell SignalingSst2 Gene ExpressionMedicine	1997	105
Direct Inhibitory Effects of a Somatostatin Analog, SMS 201-995, on AR4-2J Cell Proliferation via Pertussis Toxin-Sensitive Guanosine Triphosphate-Binding Protein-Independent Mechanism* Nathalie Viguerie, N. Tahiri‐Jouti, Anne-Marie Ayral, Endocrinology	1989	103
Gene Therapy for Pancreatic Carcinoma: Local and Distant Antitumor Effects after Somatostatin Receptor sst2 Gene Transfer Philippe Rochaix, Nathalie Delesque, J.P. Estève, Human Gene Therapy Tumor BiologyPancreatic CancerOncogenic AgentMedicineImmunology	1999	92
Effects of Somatostatin-14 and Somatostatin-28 on Bombesin-Stimulated Release of Gastrin, Insulin, and Glucagon in the Dog* Nicole Vaysse, Lucien Pradayrol, Jean‐Alain Chayvialle, Endocrinology ImmunologyGastroenterologyPharmacotherapyGastrointestinal Peptide HormoneSomatostatin Tetradecapeptide	1981	57
Binding of somatostatin to pancreatic acinar cells J.P. Estève, C. Susini, N. Vaysse, American Journal of Physiology-Gastrointestinal and Liver Physiology Cellular PhysiologyPancreatic CancerPancreatic Acinar CellsCell SurfaceAdded Ca2+	1984	56
Induction of a negative autocrine loop by expression of sst2 somatostatin receptor in NIH 3T3 cells. Isabelle Rauly, Nathalie Saint‐Laurent, Nathalie Delesque, Journal of Clinical Investigation T-regulatory CellImmunologyPathologyImmunologic MechanismSst2-induced Inhibition	1996	52
Somatostatin 28: Comparison with somatostatin 14 for plasma kinetics and low-dose effects on the exocrine pancreas in dogs Nicole Vaysse, Jean‐Alain Chayvialle, Lucien Pradayrol, Gastroenterology Animal PhysiologySomatostatin 14Plasma KineticsMedicinePhysiology	1981	47

Page 1